The World Health Organization (WHO) classifies depression as the leading cause of disability worldwide, affecting approximately 332 million people globally. That figure represents about 5.7% of all adults, making depression one of the most common health conditions on the planet and a major focus of WHO’s global health agenda.
How Many People Are Affected
About 4% of the entire global population lives with depression, but the burden is not evenly distributed. Women are significantly more affected than men: 6.9% of adult women experience depression compared to 4.6% of adult men. Adults over 70 also face elevated rates, with 5.9% affected in that age group.
Among adolescents, the numbers are striking. U.S. data from the CDC shows that roughly 19% of people ages 12 to 19 meet criteria for depression, with adolescent girls affected at more than double the rate of boys (26.5% versus 12.2%). Nearly 88% of adolescents and adults with depression report that it makes everyday activities like school, work, or maintaining relationships at least somewhat harder. About a third describe that difficulty as very to extremely severe.
Between 2005 and 2015, global depression cases rose by more than 18%, a trend driven partly by population growth and aging but also by increasing recognition of the condition.
What Counts as Depression
The WHO’s international classification system groups depressive symptoms into clusters: mood symptoms (persistent sadness and loss of interest or pleasure), cognitive symptoms (trouble concentrating, feelings of worthlessness, thoughts of death), behavioral symptoms (social withdrawal, reduced activity), and physical symptoms (changes in sleep, appetite, or energy). A formal diagnosis requires at least five of these symptoms, and at least one must come from the mood cluster. The symptoms need to persist for most of the day, nearly every day, over a minimum period of about two weeks.
When depression continues without meaningful relief for more than two years, it’s classified as persistent depressive disorder. This distinction matters because long-duration depression often requires different treatment strategies and tends to have a deeper impact on daily functioning.
Key Risk Factors
Depression is not caused by a single factor. The WHO emphasizes that social, economic, and environmental conditions shape mental health across the lifespan, beginning before birth and continuing through old age. The relationship between inequality and depression is direct: the greater the social inequality in a community, the higher the rates of depression within it.
Poverty, unemployment, exposure to violence, chronic physical illness, substance use, and social isolation all increase risk. So do major life disruptions like bereavement, relationship breakdown, or forced displacement. Biological factors play a role too, including genetics and hormonal shifts during puberty, pregnancy, and menopause, which partly explains the gender gap in prevalence. But the WHO’s framing consistently highlights that the conditions of everyday life, not just individual biology, are the primary drivers.
The Global Treatment Gap
One of the most concerning aspects of depression globally is how few people receive any care at all. In low-income countries, fewer than 10% of people with depression get treatment. Even in wealthier nations, the figure only rises to around 50%. That means hundreds of millions of people are navigating depression without professional support of any kind.
The consequences of this gap extend beyond individual suffering. Depression is closely linked to suicide, which claimed an estimated 727,000 lives worldwide in 2021. Among people ages 15 to 29, suicide is the third leading cause of death overall and the second leading cause among young women. Effective depression treatment is one of the most important tools for reducing suicide risk, which makes the treatment gap a public health emergency in its own right.
WHO-Recommended Treatments
The WHO’s treatment guidelines for depression, developed specifically for use in primary care and community settings worldwide, recommend two categories of first-line treatment: talk therapy and antidepressant medication. These can be used individually or in combination depending on severity.
On the therapy side, three approaches have the strongest evidence. Behavioral activation focuses on helping people re-engage with activities that provide a sense of accomplishment or pleasure, breaking the cycle of withdrawal that depression reinforces. Cognitive behavioral therapy works on identifying and shifting the thought patterns that sustain depressive episodes. Interpersonal therapy targets relationship difficulties and life transitions that may be triggering or maintaining symptoms.
For medication, the WHO recommends two classes of antidepressants as first-line options. These work by increasing the availability of chemical messengers in the brain that regulate mood and motivation. The choice between therapy, medication, or both depends on what’s available, what the person prefers, and how severe the depression is. For mild to moderate cases, therapy alone is often effective. For more severe episodes, combining the two tends to produce better outcomes than either one alone.
Why the WHO Prioritizes Depression
Depression generates more disability globally than any other health condition. That ranking, which the WHO has maintained for years, reflects not just how common depression is but how profoundly it impairs functioning. People with depression miss more days of work, have higher rates of chronic physical illness, and use more healthcare resources than people without it. The economic costs run into hundreds of billions of dollars annually across lost productivity and increased medical spending.
The WHO’s response has centered on making basic depression care available outside of specialist settings. Their Mental Health Gap Action Programme provides simplified protocols that general practitioners, nurses, and community health workers can use to identify and treat depression even in areas with no psychiatrists. The goal is pragmatic: since most of the world’s population will never see a mental health specialist, effective care has to be embedded in the systems people already use.